Literature DB >> 10575579

Pregnancy rate in IVF rescue in high responders to human menopausal gonadotropin.

A Many1, F Azem, J B Lessing, I Yovel, H Yavetz, A Amit.   

Abstract

PURPOSE: In vitro fertilization had been previously suggested by us as a means of "rescue" for patients with imminent ovarian hyperstimulation syndrome (OHSS) during treatment with human menopausal gonadotropin (hMG). We evaluated the pregnancy rate of rescued IVF cycles.
METHODS: During the years 1994-1995, women treated with hMG and at risk of developing OHSS were referred to our IVF unit. Their estradiol level was above 1500 pg/ml, and eight or more follicles were observed by ultrasonography in all the patients. These high responders were offered the option to undergo ovum aspiration. We report the pregnancy rate in this group of patients.
RESULTS: Thirty-nine women were referred to our unit for rescue IVF. Two were uneligible due to high progesterone concentrations. Thirty-seven women underwent ovum pickup and 32 had embryo transfer. The clinical pregnancy rate was 40% (13/32). Only two women had clinical OHSS.
CONCLUSIONS: We suggest that rescue IVF may be considered in hMG cycles of high responders with imminent OHSS. Rescue IVF offers a high rate of conception, avoids high-order multiple pregnancy, and appears not to increase the risk of OHSS in these women.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10575579      PMCID: PMC3455378          DOI: 10.1023/a:1020593003417

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  7 in total

1.  Results of gonadotrophin stimulation with the option to convert cycles to in vitro fertilization in cases of multifollicular development.

Authors:  C Bergh; I Bryman; L Nilsson; P O Janson
Journal:  Acta Obstet Gynecol Scand       Date:  1998-01       Impact factor: 3.636

2.  Triggering of ovulation using a gonadotrophin-releasing hormone agonist does not prevent ovarian hyperstimulation syndrome.

Authors:  S van der Meer; J Gerris; M Joostens; B Tas
Journal:  Hum Reprod       Date:  1993-10       Impact factor: 6.918

Review 3.  Use of gonadotropin-releasing hormone agonist to cause ovulation and prevent the ovarian hyperstimulation syndrome.

Authors:  J Itskovitz-Eldor; J Levron; S Kol
Journal:  Clin Obstet Gynecol       Date:  1993-09       Impact factor: 2.190

4.  Triggering of ovulation by a gonadotropin releasing hormone agonist in gonadotropin-stimulated cycles for prevention of ovarian hyperstimulation syndrome and multiple pregnancy.

Authors:  J Balasch; R Tur; M Creus; R Buxaderas; F Fábregues; J L Ballescá; P N Barri; J A Vanrell
Journal:  Gynecol Endocrinol       Date:  1994-03       Impact factor: 2.260

5.  Outcome of treatment subsequent to the elective cryopreservation of all embryos from women at risk of the ovarian hyperstimulation syndrome.

Authors:  I Wada; P L Matson; S A Troup; S Hughes; P Buck; B A Lieberman
Journal:  Hum Reprod       Date:  1992-08       Impact factor: 6.918

6.  Avoidance of cancellation of potential hyperstimulation cycles by conversion to in vitro fertilization-embryo transfer.

Authors:  J B Lessing; A Amit; Y Libal; I Yovel; A Kogosowski; M R Peyser
Journal:  Fertil Steril       Date:  1991-07       Impact factor: 7.329

7.  Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist.

Authors:  J Itskovitz; R Boldes; J Levron; Y Erlik; L Kahana; J M Brandes
Journal:  Fertil Steril       Date:  1991-08       Impact factor: 7.329

  7 in total
  1 in total

1.  Rescue in vitro fertilization using a GnRH antagonist in hyper-responders from gonadotropin intrauterine insemination (IUI) cycles.

Authors:  Jacques Balayla; Louis Granger; Pierre St-Michel; Marc Villeneuve; Jean-Yves Fontaine; Pascal Desrosiers; Elias M Dahdouh
Journal:  J Assist Reprod Genet       Date:  2013-05-30       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.